| Variable  | 
        Thiamine Treatment  | 
        Placebo | 
      
      
      
        |   | 
        Baseline  | 
        Therapy  | 
        Washout  | 
        Baseline  | 
        Therapy  | 
        Washout  | 
      
      
        | Plasma thiamine (nM/l)  | 
        10.6 (0.8–84.5)  | 
        98.2 (2.6–294.5) c, f  | 
        10.9 (3.6–22.7) i  | 
        7.1 (1.1–31.3)  | 
        7.1 (2.4–16.6)  | 
        9.1 (4.2–16.3)  | 
      
      
      
      
        |  Urinary thiamine (µmol/24 h)  | 
        1.63 (0.45–7.66)  | 
        47.69 (0.40–182.79) c,f  | 
        1.42 (0.10–9.72) i  | 
        1.53 (0.67–4.46)  | 
        1.71 (0.15–9.73)  | 
        1.16 (0.00–5.44)  | 
      
      
      
        | Urinary albumin    Excretion   (mg/24 h)(30-300 MAU)  | 
        43.7 (33.0–120.9)  | 
        30.1 (12.0–38.2)b,f | 
        20.9 (7.0–35.0)f,h | 
        50.9 (33–122)  | 
        35.5 (6.4–82.0)  | 
        30 (3.5–80.4)f  | 
      
      
        | Thiamine    clearance(ml/min)  | 
        112 (8-819)  | 
        273(3-789)d  | 
        92(18-237)h  | 
        189(26-955)  | 
        149 (12-663)  | 
        102(12-334)e  | 
      
      
        | Plasma glucose    (mg/dl)(>126)  | 
        181.8±57.6  | 
        181.8±70.2  | 
        144±6.3d  | 
        177.58±55.8  | 
        158.4±43.24  | 
        144±55.8d  | 
      
      
        | Glycated HbAic% (>7    diabetes)  | 
        9.2±1.3  | 
        9.0±1.8  | 
        7.8±1.6     e,h  | 
        8.8±1.8  | 
        8.5±1.7  | 
        8.4±1.7  | 
      
     
      
        | Total cholesterol    (mg/dl) 200- 299)(high)  | 
        203.40±50.27  | 
        188.32 (100.15-
          374.90) | 
        178.26
          (127.22–278.42)  | 
         
            185.22±40.98  | 
        171.30±64.19  | 
        215.39±76.7h  | 
      
      
        | LDL-cholesterol (mg/dl)  (130-159(borderline high)  | 
        106.34±47.14  | 
        98.996±66.12  | 
        93.19±32.09a  | 
        106.34±35.96  | 
        92.05±460.01  | 
        123.35±47.95g  | 
      
      
        | VLDL(mg/dl)(    40-100(high)  | 
        46.330±31.792  | 
        55.62±36.46b  | 
        48.260± 30.62  | 
        31.30 ±16.339  | 
        36.425±17.24d  | 
        38.760 ± 13.9 e  | 
      
      
        | HDL-cholesterol    (mg/dl)(F<50,M<40)increased risk of coronary artery disease  | 
        49.88±13.53  | 
        41.76±14.30d  | 
        44.47±9.28  | 
        47.95±10.44  | 
        37.50±8.89f  | 
        52.97±21.65h  | 
      
      
        | Triacylglycerol (mg/dl) (200-499 high), | 
        198.47 (53.4-
          739.59) | 
        202.03 (81.66-
          620.73) | 
        231.4(79.21-
          736.03) | 
        134.39(72.98-
          377.3) | 
        159.31 (56.07-
          357.78)d | 
        175.33 (96.12-
          396.94)d | 
      
      
        | BILIRUBIN(0.1-1mg/dl)  | 
        0.550±0.244  | 
        0.470±0.194 e  | 
        0.503±0.24  | 
        0.514±0.283  | 
        0.382±0.185g  | 
		  | 
      
      
        | ALP(U/L)20-160  | 
        103.30±33.48  | 
        102.85±33.25  | 
        91.10±24. 83  | 
        88.20±29.84  | 
        80.65±44.75  | 
        84.1±34.15  | 
      
      
        | ALT(U/L)30-65  | 
        360.05±10.49  | 
        31.15±    10.36  | 
        32.10±10.59  | 
        36.10±10.40  | 
        31.85±11.41  | 
        36.20±15.81  | 
      
      
        | AST(U/L)15-37  | 
        22.60±9.70  | 
        19.00    ± 7.21  | 
        22.15±9.36  | 
        21.65±7.70  | 
        15.95±8.80    d  | 
        20.55±5.68  |